We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App





Samsung Ushers in New Era of Diagnostic Solutions

By MedImaging International staff writers
Posted on 27 Nov 2023
Print article
Image: The state-of-the-art OmniTom Elite with Photon Counting Detector technology is on display at RSNA 2023 (Photo courtesy of Samsung)
Image: The state-of-the-art OmniTom Elite with Photon Counting Detector technology is on display at RSNA 2023 (Photo courtesy of Samsung)

NeuroLogica Corp., a subsidiary of Samsung Electronics (Suwon-si, South Korea), is showcasing its latest offerings in mobile computed tomography (CT) and featuring the OmniTom Elite Photon Counting mobile CT scanner at the Radiological Society of North America (RSNA) Annual Meeting.

The clinical launch of the OmniTom Elite with PCD, the first US FDA 510(k) cleared single-source photon counting CT scanner with a single detector on a mobile system, is being featured at this year’s meeting. Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field, capturing the X-ray photons directly at the detector and converting the energy to electrical signals. The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department, expanding the diagnostic possibilities of CT at the patient’s bedside.

The OmniTom Elite mobile CT scanners were designed keeping in mind upgrading capabilities. In the near term, all current OmniTom users will have the opportunity to upgrade their scanners with the PCD technology. NeuroLogica has built on design features from the first US FDA US 510(k) clearance in 2022 to the second one in June 2023 to include high-resolution mode scanning and multi-energy CT functionality with spectral capability for material decomposition and virtual monoenergetic images (VMI). NeuroLogica is unveiling the OmniTom Elite with PCD and offering a live demonstration of this state-of-the-art technology at Booth #6113. In addition, NeuroLogica is hosting the Samsung NeuroLogica Lunch & Learn Event “Photon Counting: The Next Generation of Neuro CT” where industry experts will discuss how leveraging the latest innovation in CT applications can increase productivity and enhance the patient and physician experience.

“The OmniTom Elite is an advanced imaging solution that is extremely mobile, giving healthcare providers more flexibility in when and where they run diagnostic tests for their patients,” said Renaud Maloberti, Head of Business, MCT. “We look forward to featuring this innovative technology at this year’s Radiological Society of North America Annual Meeting.”

Related Links:
Samsung Electronics 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Software
UltraExtend NX
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
X-Ray Detector
FDR-D-EVO III

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.